Therefore, the present study may provide some novel insights of the potential mechanism that Ang II activates the ERK1/2 and JNK pathways via ATIR to promote osteoclast formation and bone destruction in RA patients, which require further elucidation. This evidence concerns the gene MAPK3 and rheumatoid arthritis.